Daily briefing: Australia will be first to prescribe these psychedelics as medicines
No abstract is available for this record.
Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Bibliographic context
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-01Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-02-25THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”Drug Science Policy and Law · 2026-05-31Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibilityFrontiers in Neuroscience · 2026-03-22PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONSInternational Journal of Innovative Technologies in Social Science · 2026-03-18Electrical brain changes following psilocybin administration in sprague-dawley ratsNeuroscience Applied · 2025-12-31Psychedelics in Practice: Science, Safety, and the Future of HealingThe proceedings of sliit international conference on advancements in science and humanities · 2025-10-09